Rangering i aksjer
#11871
OmniAb, Inc. is an American biotechnology firm focused on pioneering... OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Aksjekurs
$4.48
Sist synkronisert: 2026-08-28
Handel OmniAb, Inc. (OABI)
Pris OABI pris med markedsverdi på B
Markedsverdi av OmniAb, Inc.(OABI)
Markedsverdi: $649.33M
Per August 2026 har OmniAb, Inc. en markedsverdi på $649.33M. Dette gjør OmniAb, Inc. til det 11871st mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for OmniAb, Inc. fra 2021 til 2026
OABI sammenlignet med topp 5 mest populære stocks
| Pris på OABI |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.264T
|
+810,558.71%
|
|
|
|
|
$4.701T
|
+723,917.10%
|
|
|
|
|
$4.177T
|
+643,203.69%
|
|
|
|
|
$3.817T
|
+587,796.51%
|
|
|
|
|
$2.866T
|
+441,328.44%
|
